Inventor · disambiguated record
Wenxin Gu
Also filed as: GU WENXIN
27 granted patents·9 pending applications·194 citations·filing 2004–2023
96Inventor score
Top patents by PatentIndex Score
36 records- 0196US9518056B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Dec 13, 2016·16 cites·4 claims
- 0296US9394302B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2015·Granted Jul 19, 2016·19 cites·6 claims
- 0396US9051319B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Jun 9, 2015·24 cites·2 claims
- 0495US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0595US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 0695US8829007B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Granted Sep 9, 2014·28 cites·2 claims
- 0794US9808459B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Nov 7, 2017·11 cites·8 claims
- 0894US9345708B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2014·Granted May 24, 2016·21 cites·16 claims
- 0993US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 1092US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 1192US10039762B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2017·Granted Aug 7, 2018·7 cites·2 claims
- 1292US9908878B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2016·Granted Mar 6, 2018·8 cites·16 claims
- 1390US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 1489US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 1588US11059826B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2019·Granted Jul 13, 2021·3 cites·49 claims
- 1686US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 1786US11572364B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2021·Granted Feb 7, 2023·1 cites·48 claims
- 1877US10118904B2Triazoles for the treatment of Demyelinating DiseasesVERTEX PHARMA·Filed 2016·Granted Nov 6, 2018·3 cites·34 claims
- 1977US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2076US12384790B2Pteridinone compounds and uses thereofVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·20 claims
- 2176US11813267B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2020·Granted Nov 14, 2023·0 cites·19 claims
- 2269US2018311254A1Dna-pk inhibitorsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2368US10874673B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·30 claims
- 2467US2021040092A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2020·Application pending·0 cites
- 2565US10875855B2Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2018·Granted Dec 29, 2020·0 cites·16 claims
- 2664US2016354381A1Dna-pk inhibitorsObligated Assignee·Filed 2016·Application pending·0 cites
- 2755US10766869B2Triazoles for the treatment of demyelinating dieasesVERTEX PHARMA·Filed 2018·Granted Sep 8, 2020·0 cites·34 claims
- 2855US8492345B2Cyclic peptide antitumor agentsSILVERMAN RICHARD B·Filed 2011·Granted Jul 23, 2013·0 cites·12 claims
- 2955US7709443B2Cyclic peptide antitumor agentsUNIV NORTHWESTERN·Filed 2004·Granted May 4, 2010·0 cites·12 claims
- 3055US2012171245A1Inhibitors of influenza viruses replicationCHARIFSON PAUL S·Filed 2011·Application pending·0 cites
- 3154US12502376B2Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)VERTEX PHARMA·Filed 2021·Granted Dec 23, 2025·0 cites·33 claims
- 3253US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3352US2023159521A11h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3448US8058244B2Cyclic peptide antitumor agentsSILVERMAN RICHARD B·Filed 2010·Granted Nov 15, 2011·0 cites·8 claims
- 3545US2013345218A1Inhibitors of influenza viruses replicationVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 3639US2018251431A11,3-substituted pyrazole compounds useful for reduction of very long chain fatty acid levelsVERTEX PHARMA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wenxin Gu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →